Rob Brierley
@robbrierley.bsky.social
1.3K followers
520 following
290 posts
Editor-in-Chief, The Lancet Gastroenterology & Hepatology @lancetgastrohep.bsky.social.
Views my own; reposting ≠ endorsement. #GastroSky #LiverSky #GISky #OncSky
Posts
Media
Videos
Starter Packs
Reposted by Rob Brierley
Reposted by Rob Brierley
The Lancet
@thelancet.com
· 23h
Efficacy of behavioural therapies for irritable bowel syndrome: a systematic review and network meta-analysis
Several behavioural therapies are efficacious for global symptoms in IBS, although
the most evidence exists for those classed as brain–gut behaviour therapies. However,
certainty in the evidence for a...
www.thelancet.com
Reposted by Rob Brierley
Reposted by Rob Brierley
Reposted by Rob Brierley
Reposted by Rob Brierley
Reposted by Rob Brierley
Reposted by Rob Brierley
Reposted by Rob Brierley
Reposted by Rob Brierley
Reposted by Rob Brierley
Reposted by Rob Brierley
Reposted by Rob Brierley
Reposted by Rob Brierley
Reposted by Rob Brierley
Reposted by Rob Brierley
Reposted by Rob Brierley
Reposted by Rob Brierley
Reposted by Rob Brierley
Reposted by Rob Brierley
Rob Brierley
@robbrierley.bsky.social
· Aug 28
Targeting alcohol use in high-risk population groups: a US microsimulation study of beverage-specific pricing policies
Disproportionate increases in retail prices for the cheapest beverages, beer and spirits,
might lead to a greater decline in consumption among high-risk groups. Pricing policies
could thus be used as ...
www.thelancet.com